Spectrin, Beta, Non-erythrocytic 2 (SPTBN2) (AA 2340-2390) anticorps
Aperçu rapide pour Spectrin, Beta, Non-erythrocytic 2 (SPTBN2) (AA 2340-2390) anticorps (ABIN7450766)
Antigène
Voir toutes Spectrin, Beta, Non-erythrocytic 2 (SPTBN2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 2340-2390
-
Fonction
- Rabbit anti-SPTBN2/SCA5 Antibody, Affinity Purified
-
Homologie
- Rat
-
Purification
- Affinity Purified
-
Immunogène
- between AA 2340 and 2390
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IP: 2 - 10 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 200 μg/mL
-
Buffer
- Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Date de péremption
- 12 months
-
-
- Spectrin, Beta, Non-erythrocytic 2 (SPTBN2)
-
Autre désignation
- SPTBN2/SCA5
-
Sujet
- Background: SPTBN2/SCA5 is a member of the beta spectrin gene family and a subunit of the spectrin cytoskeletal scaffolding protein that links the plasma membrane to cytoskeletal actin and functions in cellular shape and organelle organization. SPTBN2/SCA5 has been identified as a Golgi- and vesicle-associated spectrin. Mutations in SPTBN2/SCA5 cause spinocerebellar ataxia type 5 (SCA5), an autosomal dominant disease characterized by progressive incoordination of gait, hand, speech, and eye movements.
-
ID gène
- 6712
-
NCBI Accession
- NP_008877
-
UniProt
- O15020
-
Pathways
- Regulation of Actin Filament Polymerization, Synaptic Vesicle Exocytosis
Antigène
-